Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
CEO Spotlight: Gaston Salinas
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
The Transformative Potential of Gene Therapy
Parenteral Perspectives
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Immunome Promotes Max Rosett to Chief Financial Officer
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Johnson & Johnson Agrees to Acquire Proteologix
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
Galapagos, Blood Centers of America Enter Strategic CAR-T Mfg. Pact
Veeva Systems Introduces Veeva Vault Basics
Examining the Role of AI in Supply Chain Management Across the Bio/Pharma Industry
Scorpius Earns cGMP Facility Validation for Microbial Manufacturing
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Pharma Matters Q&A: PCI Pharma Services
Pharma Matters Q&A: Marken
Parenteral Perspectives
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
Clinical Trial Modernization - Optimizing the Supply of Decentralized Studies
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Advance Microbial Detection with Metagenomic Techniques
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
BMS’s CAR T Cell Therapy Breyanzi Approved for Follicular Lymphoma
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
The Future of Pharmacovigilance is Proactive
Parenteral Perspectives
"3 Key Trends" with Rob Feltz
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
August Bioservices
Abzena
INCOG BioPharma Services
BioTechnique
SUANFARMA CDMO
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
August Bioservices
Abzena
INCOG BioPharma Services
BioTechnique
SUANFARMA CDMO
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Drug Discovery And Development
Features
All
Analytical Services
Bioanalytical Services
Bioassay Development
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Laboratory Testing
Advance Microbial Detection with Metagenomic Techniques
Microbial detection is arguably more important than ever.
Online Exclusives
Emily Newton, Contributing Writer
05.17.24
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies for cancer.
05.17.24
Breaking News
|
Clinical Trials
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Will advance NVL-655 in recognition of the continued need for innovation for patients with ALK-positive NSCLC who have exhausted available therapies.
05.17.24
Breaking News
|
cGMP Manufacture
|
Chemistry
|
Industry News
|
Information Technology
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
Aims to enable development of optimized manufacturing processes in a fraction of the time versus historical methods.
05.16.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Trials & Filings
BMS’s CAR T Cell Therapy Breyanzi Approved for Follicular Lymphoma
Overall response rate was 95.7%, as defined as the percentage of patients achieving a partial or complete response.
05.16.24
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
Sartorius Expands AI Alliance with NVIDIA
Will combine Sartorius’ knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software.
05.16.24
Bio News
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Promotions & Moves
Regulus Therapeutics Names New Chief Medical Officer
Dr. Rekha Garg is a physician executive with over 20 years of experience in leadership roles in the biopharma industry.
05.16.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
U.S. Biosecure Act Advances with Revised Timeline
WuXi Biologics added to list of biotech companies of concern, now provides U.S. companies until 2032 to find new service providers.
05.15.24
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
Aim to transform outcomes for patients with multiple types of cancer.
05.14.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Centogene and Evotec Discover New Potential Treatment for Gaucher Disease
Companies amend existing drug discovery partnership for Evotec to lead continued development.
05.14.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Takeda, AC Immune Ink Exclusive Agreement for Alzheimer’s Immunotherapy
Worldwide option and license agreement includes AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060.
05.14.24
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
Aim to create opportunities to target previously undruggable disease-causing proteins.
05.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP Encapsulation
Collaboration increases Aldevron’s services and capabilities as an mRNA sequence-to-vial custom manufacturer.
05.14.24
Information Technology
|
Regulatory Affairs
The Future of Pharmacovigilance is Proactive
Data and AI can unlock the path to proactivity.
Bruce Palsulich, Vice President of Safety, Oracle Life Sciences
05.13.24
Analytical Services
|
Chemistry
|
Laboratory Testing
|
R&D
A New Approach to Particle Morphology
The particle size of the API and excipients affects more than just the stability and appearance of the product.
Emil W. Ciurczak, Contributing Writer
05.13.24
Biologics, Proteins, Vaccines
CEO Spotlight: Gaston Salinas
The chief executive of Botanical Solution Inc. (BSI) speaks about the development of QS-21 adjuvant for vaccines from Quillaja saponaria trees grown in BSI labs
Tim Wright, Editor, Contract Pharma
05.13.24
Formulation Development
|
Process Development
|
Scale-up/Technology Transfer
Three Key Considerations of Complex Liquid Formulations
In this white paper, we delve into three key factors that affect your product across its lifecycle.
05.13.24
Biologics, Proteins, Vaccines
|
Drug Development
The Transformative Potential of Gene Therapy
Gene therapy is having its moment. Can the clinical research ecosystem seize it?
James Riddle, Senior Vice President, Global Review Operations, Advarra
05.13.24
Biologics, Proteins, Vaccines
|
Drug Development
CDMOs: The Cornerstone of Biopharmaceutical Innovation
CDMOs provide specialized support, knowledge, and infrastructure to accelerate drug development and get new drugs to the market sooner.
Leonardo Magneschi, Head of Molecular Biology, Ingenza
05.13.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Promotions & Moves
ERS Genomics Appoints John E. Milad CEO
John brings more than 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences.
05.13.24
Breaking News
Immunome Promotes Max Rosett to Chief Financial Officer
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Johnson & Johnson Agrees to Acquire Proteologix
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
View Breaking News >
CURRENT ISSUE
May 2024
CDMOs: The Cornerstone of Biopharmaceutical Innovation
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
CEO Spotlight: Gaston Salinas
Parenteral Perspectives
The Transformative Potential of Gene Therapy
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
View More >